Outcomes in ankylosing spondylitis: what makes the assessment of treatment effects in ankylosing spondylitis different?
- PMID: 17038467
- PMCID: PMC1798377
- DOI: 10.1136/ard.2006.058461
Outcomes in ankylosing spondylitis: what makes the assessment of treatment effects in ankylosing spondylitis different?
Abstract
There are four major challenges in the assessment of outcomes in patients with ankylosing spondylitis (AS) that are particularly relevant to the evaluation of new therapies. Firstly, measures of symptoms and impairment in AS are not specific for inflammatory processes, they also capture mechanical symptoms and fixed limitations. The non-specific nature of these measures may cause them to be less responsive and therefore less useful in determining treatment efficacy. Secondly, acute phase reactants have limited value as measures of AS activity and other surrogate markers have not yet been established. Thirdly, the assessment of the disease modifying potential of new therapies is hampered by the slow rate of spinal fusion. Fourthly, work disability has not be studied as an endpoint in clinical trials in AS, despite the fact that work disability is an important outcome in patients with AS. Research into ways to overcome these challenges in outcome measurement will help identify useful therapies and define the range of outcomes that they influence.
Conflict of interest statement
Competing interests: none declared
References
-
- Ward M M. Assessment of health outcomes. In: Harris ED Jr, ed. Kelley's Textbook of Rheumatology, 7th edn. Philadelphia: Elsevier Science, 2005435–446.
-
- World Health Organization ICF: International Classification of Functioning, Disability, and Health. Introduction. Geneva: World Health Organization, 2001. Available at: www3.who.int/icf/icftemplate.cfm (accessed 5 December 2001)
-
- van der Heidje D, van der Linden S, Bellamy N, Calin A, Dougados M, Khan M A. Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV. J Rheumatol 199926945–947. - PubMed
-
- van der Heidje D, Calin A, Dougados M, Khan M A, van der Linden S, Bellamy N. Selection of instruments in the core set for DC‐ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessment in Ankylosing Spondylitis. J Rheumatol 199926951–954. - PubMed
-
- Rudawleit M, Hilgert E, Haibel H, Sieper J. Evaluation of a spinal pain score performed by the rheumatologist in ankylosing spondylitis [abstract]. European League Against Rheumatism Scientific Meeting, 12–15 June 2003, Lisbon, Portugal
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
